H

Huakang Biomedical Holdings Co Ltd
HKEX:8622

Watchlist Manager
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Watchlist
Price: 0.184 HKD -0.54% Market Closed
Market Cap: 92.1m HKD
Have any thoughts about
Huakang Biomedical Holdings Co Ltd?
Write Note

Huakang Biomedical Holdings Co Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Huakang Biomedical Holdings Co Ltd
Total Equity Peer Comparison

Comparables:
K
876
K
1134
1120
O
6929

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
H
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Total Equity
ÂĄ51m
CAGR 3-Years
-6%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
K
Kaisa Health Group Holdings Ltd
HKEX:876
Total Equity
HK$457.8m
CAGR 3-Years
-13%
CAGR 5-Years
-15%
CAGR 10-Years
12%
K
Kelfred Holdings Ltd
HKEX:1134
Total Equity
HK$183.2m
CAGR 3-Years
0%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Arts Optical International Holdings Ltd
HKEX:1120
Total Equity
HK$516.8m
CAGR 3-Years
6%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
O
OrbusNeich Medical Group Holdings Ltd
HKEX:6929
Total Equity
$368.4m
CAGR 3-Years
119%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Huakang Biomedical Holdings Co Ltd's Total Equity?
Total Equity
51m CNY

Based on the financial report for Dec 31, 2023, Huakang Biomedical Holdings Co Ltd's Total Equity amounts to 51m CNY.

What is Huakang Biomedical Holdings Co Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
-6%

Over the last year, the Total Equity growth was -10%. The average annual Total Equity growth rates for Huakang Biomedical Holdings Co Ltd have been -6% over the past three years , -6% over the past five years .

Back to Top